Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Esketamine Market Growth 2022-2028

  • LP 4803088
  • 96 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Esketamine will have significant change from previous year. According to our (LP Information) latest study, the global Esketamine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Esketamine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Esketamine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Esketamine market, reaching US$ million by the year 2028. As for the Europe Esketamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Esketamine players cover Merck, Medkoo, Endo International, and Janssen Pharmaceutica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral Medications

Injection

Nasal Spray

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

General Anesthetic

Treatment-resistant Depression

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Medkoo

Endo International

Janssen Pharmaceutica

PFIZER

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Esketamine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Esketamine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Esketamine by Country/Region, 2017, 2022 & 2028

2.2 Esketamine Segment by Type

2.2.1 Oral Medications

2.2.2 Injection

2.2.3 Nasal Spray

2.3 Esketamine Sales by Type

2.3.1 Global Esketamine Sales Market Share by Type (2017-2022)

2.3.2 Global Esketamine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Esketamine Sale Price by Type (2017-2022)

2.4 Esketamine Segment by Application

2.4.1 General Anesthetic

2.4.2 Treatment-resistant Depression

2.5 Esketamine Sales by Application

2.5.1 Global Esketamine Sale Market Share by Application (2017-2022)

2.5.2 Global Esketamine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Esketamine Sale Price by Application (2017-2022)

3 Global Esketamine by Company

3.1 Global Esketamine Breakdown Data by Company

3.1.1 Global Esketamine Annual Sales by Company (2020-2022)

3.1.2 Global Esketamine Sales Market Share by Company (2020-2022)

3.2 Global Esketamine Annual Revenue by Company (2020-2022)

3.2.1 Global Esketamine Revenue by Company (2020-2022)

3.2.2 Global Esketamine Revenue Market Share by Company (2020-2022)

3.3 Global Esketamine Sale Price by Company

3.4 Key Manufacturers Esketamine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Esketamine Product Location Distribution

3.4.2 Players Esketamine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Esketamine by Geographic Region

4.1 World Historic Esketamine Market Size by Geographic Region (2017-2022)

4.1.1 Global Esketamine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Esketamine Annual Revenue by Geographic Region

4.2 World Historic Esketamine Market Size by Country/Region (2017-2022)

4.2.1 Global Esketamine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Esketamine Annual Revenue by Country/Region

4.3 Americas Esketamine Sales Growth

4.4 APAC Esketamine Sales Growth

4.5 Europe Esketamine Sales Growth

4.6 Middle East & Africa Esketamine Sales Growth

5 Americas

5.1 Americas Esketamine Sales by Country

5.1.1 Americas Esketamine Sales by Country (2017-2022)

5.1.2 Americas Esketamine Revenue by Country (2017-2022)

5.2 Americas Esketamine Sales by Type

5.3 Americas Esketamine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Esketamine Sales by Region

6.1.1 APAC Esketamine Sales by Region (2017-2022)

6.1.2 APAC Esketamine Revenue by Region (2017-2022)

6.2 APAC Esketamine Sales by Type

6.3 APAC Esketamine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Esketamine by Country

7.1.1 Europe Esketamine Sales by Country (2017-2022)

7.1.2 Europe Esketamine Revenue by Country (2017-2022)

7.2 Europe Esketamine Sales by Type

7.3 Europe Esketamine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Esketamine by Country

8.1.1 Middle East & Africa Esketamine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Esketamine Revenue by Country (2017-2022)

8.2 Middle East & Africa Esketamine Sales by Type

8.3 Middle East & Africa Esketamine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Esketamine

10.3 Manufacturing Process Analysis of Esketamine

10.4 Industry Chain Structure of Esketamine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Esketamine Distributors

11.3 Esketamine Customer

12 World Forecast Review for Esketamine by Geographic Region

12.1 Global Esketamine Market Size Forecast by Region

12.1.1 Global Esketamine Forecast by Region (2023-2028)

12.1.2 Global Esketamine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Esketamine Forecast by Type

12.7 Global Esketamine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Esketamine Product Offered

13.1.3 Merck Esketamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Medkoo

13.2.1 Medkoo Company Information

13.2.2 Medkoo Esketamine Product Offered

13.2.3 Medkoo Esketamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Medkoo Main Business Overview

13.2.5 Medkoo Latest Developments

13.3 Endo International

13.3.1 Endo International Company Information

13.3.2 Endo International Esketamine Product Offered

13.3.3 Endo International Esketamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Endo International Main Business Overview

13.3.5 Endo International Latest Developments

13.4 Janssen Pharmaceutica

13.4.1 Janssen Pharmaceutica Company Information

13.4.2 Janssen Pharmaceutica Esketamine Product Offered

13.4.3 Janssen Pharmaceutica Esketamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Janssen Pharmaceutica Main Business Overview

13.4.5 Janssen Pharmaceutica Latest Developments

13.5 PFIZER

13.5.1 PFIZER Company Information

13.5.2 PFIZER Esketamine Product Offered

13.5.3 PFIZER Esketamine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 PFIZER Main Business Overview

13.5.5 PFIZER Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Esketamine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Esketamine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Medications

Table 4. Major Players of Injection

Table 5. Major Players of Nasal Spray

Table 6. Global Esketamine Sales by Type (2017-2022) & (K Units)

Table 7. Global Esketamine Sales Market Share by Type (2017-2022)

Table 8. Global Esketamine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Esketamine Revenue Market Share by Type (2017-2022)

Table 10. Global Esketamine Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Esketamine Sales by Application (2017-2022) & (K Units)

Table 12. Global Esketamine Sales Market Share by Application (2017-2022)

Table 13. Global Esketamine Revenue by Application (2017-2022)

Table 14. Global Esketamine Revenue Market Share by Application (2017-2022)

Table 15. Global Esketamine Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Esketamine Sales by Company (2020-2022) & (K Units)

Table 17. Global Esketamine Sales Market Share by Company (2020-2022)

Table 18. Global Esketamine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Esketamine Revenue Market Share by Company (2020-2022)

Table 20. Global Esketamine Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Esketamine Producing Area Distribution and Sales Area

Table 22. Players Esketamine Products Offered

Table 23. Esketamine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Esketamine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Esketamine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Esketamine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Esketamine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Esketamine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Esketamine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Esketamine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Esketamine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Esketamine Sales by Country (2017-2022) & (K Units)

Table 35. Americas Esketamine Sales Market Share by Country (2017-2022)

Table 36. Americas Esketamine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Esketamine Revenue Market Share by Country (2017-2022)

Table 38. Americas Esketamine Sales by Type (2017-2022) & (K Units)

Table 39. Americas Esketamine Sales Market Share by Type (2017-2022)

Table 40. Americas Esketamine Sales by Application (2017-2022) & (K Units)

Table 41. Americas Esketamine Sales Market Share by Application (2017-2022)

Table 42. APAC Esketamine Sales by Region (2017-2022) & (K Units)

Table 43. APAC Esketamine Sales Market Share by Region (2017-2022)

Table 44. APAC Esketamine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Esketamine Revenue Market Share by Region (2017-2022)

Table 46. APAC Esketamine Sales by Type (2017-2022) & (K Units)

Table 47. APAC Esketamine Sales Market Share by Type (2017-2022)

Table 48. APAC Esketamine Sales by Application (2017-2022) & (K Units)

Table 49. APAC Esketamine Sales Market Share by Application (2017-2022)

Table 50. Europe Esketamine Sales by Country (2017-2022) & (K Units)

Table 51. Europe Esketamine Sales Market Share by Country (2017-2022)

Table 52. Europe Esketamine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Esketamine Revenue Market Share by Country (2017-2022)

Table 54. Europe Esketamine Sales by Type (2017-2022) & (K Units)

Table 55. Europe Esketamine Sales Market Share by Type (2017-2022)

Table 56. Europe Esketamine Sales by Application (2017-2022) & (K Units)

Table 57. Europe Esketamine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Esketamine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Esketamine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Esketamine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Esketamine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Esketamine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Esketamine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Esketamine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Esketamine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Esketamine

Table 67. Key Market Challenges & Risks of Esketamine

Table 68. Key Industry Trends of Esketamine

Table 69. Esketamine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Esketamine Distributors List

Table 72. Esketamine Customer List

Table 73. Global Esketamine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Esketamine Sales Market Forecast by Region

Table 75. Global Esketamine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Esketamine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Esketamine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Esketamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Esketamine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Esketamine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Esketamine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Esketamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Esketamine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Esketamine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Esketamine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Esketamine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Esketamine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Esketamine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Esketamine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Esketamine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Esketamine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Esketamine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck Esketamine Product Offered

Table 95. Merck Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Medkoo Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors

Table 99. Medkoo Esketamine Product Offered

Table 100. Medkoo Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Medkoo Main Business

Table 102. Medkoo Latest Developments

Table 103. Endo International Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors

Table 104. Endo International Esketamine Product Offered

Table 105. Endo International Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Endo International Main Business

Table 107. Endo International Latest Developments

Table 108. Janssen Pharmaceutica Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors

Table 109. Janssen Pharmaceutica Esketamine Product Offered

Table 110. Janssen Pharmaceutica Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Janssen Pharmaceutica Main Business

Table 112. Janssen Pharmaceutica Latest Developments

Table 113. PFIZER Basic Information, Esketamine Manufacturing Base, Sales Area and Its Competitors

Table 114. PFIZER Esketamine Product Offered

Table 115. PFIZER Esketamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. PFIZER Main Business

Table 117. PFIZER Latest Developments

List of Figures

Figure 1. Picture of Esketamine

Figure 2. Esketamine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Esketamine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Esketamine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Esketamine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Medications

Figure 10. Product Picture of Injection

Figure 11. Product Picture of Nasal Spray

Figure 12. Global Esketamine Sales Market Share by Type in 2021

Figure 13. Global Esketamine Revenue Market Share by Type (2017-2022)

Figure 14. Esketamine Consumed in General Anesthetic

Figure 15. Global Esketamine Market: General Anesthetic (2017-2022) & (K Units)

Figure 16. Esketamine Consumed in Treatment-resistant Depression

Figure 17. Global Esketamine Market: Treatment-resistant Depression (2017-2022) & (K Units)

Figure 18. Global Esketamine Sales Market Share by Application (2017-2022)

Figure 19. Global Esketamine Revenue Market Share by Application in 2021

Figure 20. Esketamine Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Esketamine Revenue Market Share by Company in 2021

Figure 22. Global Esketamine Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Esketamine Revenue Market Share by Geographic Region in 2021

Figure 24. Global Esketamine Sales Market Share by Region (2017-2022)

Figure 25. Global Esketamine Revenue Market Share by Country/Region in 2021

Figure 26. Americas Esketamine Sales 2017-2022 (K Units)

Figure 27. Americas Esketamine Revenue 2017-2022 ($ Millions)

Figure 28. APAC Esketamine Sales 2017-2022 (K Units)

Figure 29. APAC Esketamine Revenue 2017-2022 ($ Millions)

Figure 30. Europe Esketamine Sales 2017-2022 (K Units)

Figure 31. Europe Esketamine Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Esketamine Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Esketamine Revenue 2017-2022 ($ Millions)

Figure 34. Americas Esketamine Sales Market Share by Country in 2021

Figure 35. Americas Esketamine Revenue Market Share by Country in 2021

Figure 36. United States Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Esketamine Sales Market Share by Region in 2021

Figure 41. APAC Esketamine Revenue Market Share by Regions in 2021

Figure 42. China Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Esketamine Sales Market Share by Country in 2021

Figure 49. Europe Esketamine Revenue Market Share by Country in 2021

Figure 50. Germany Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Esketamine Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Esketamine Revenue Market Share by Country in 2021

Figure 57. Egypt Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Esketamine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Esketamine in 2021

Figure 63. Manufacturing Process Analysis of Esketamine

Figure 64. Industry Chain Structure of Esketamine

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390